Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...
The FDA has granted Fast Track designation to amezalpat (TPST-1120) for the treatment of patients with hepatocellular carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback